— Know what they know.
Not Investment Advice

HQL

Tekla Life Sciences Investors
1W: -6.8% 1M: -15.8% 3M: -12.3% YTD: +8.9% 1Y: +15.6% 3Y: +88.6% 5Y: +31.6%
$17.68
-0.49 (-2.70%)
 
Weekly Expected Move ±3.3%
$17 $17 $18 $18 $19
ETF NYSE · AUM $537.6M

Portfolio Health Summary

IS Overall Score
40.5
★★★★★
Altman Z-Score
18.99
Safe
Weight Coverage
84%
of portfolio analyzed
Holdings Matched
77
with fundamental data

InsiderStreet Scorecard

★★★★★ 40.5
Profitability
33.0
Balance Sheet
55.4
Earnings Quality
51.5
Growth
53.4
Value
34.6
Momentum
55.4
Safety
75.3

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
18.99
Safe Zone (>2.99)
Piotroski F-Score
3.4 / 9
Weak
Beneish M-Score
-1.00
Possible Manipulator
Credit Score
—
Earnings Quality
51.5 / 100

Portfolio Valuation

P/E
33.00x
P/B
4.84x
P/S
8.41x
EV/EBITDA
33.77x
EV/Revenue
9.15x
P/FCF
38.74x
P/OCF
34.55x
PEG
3.03x
Earnings Yield
3.03%
FCF Yield
2.58%
OCF Yield
2.89%
Median P/E
-7.37x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +42.4%
Net Income -10.7%
EPS +5.0%
FCF -2.2%
EBITDA -7.8%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +43.0%
Rev CAGR 5Y +34.8%
EPS CAGR 3Y +10.9%
EPS CAGR 5Y +16.4%
FCF CAGR 3Y +12.1%
FCF CAGR 5Y +82.1%
EBITDA CAGR 3Y +4.5%
EBITDA CAGR 5Y +4.9%
Payout Ratio
4.27%
Buyback Yield
0.17%
Dividend Yield
0.04%
Total Shareholder Return
-10.03%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$17.67
Median 1Y
$19.12
5th Pctile
$13.01
95th Pctile
$28.14
Ann. Volatility
23.2%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 33.00
Portfolio P/B 4.84
Portfolio P/S 8.41
EV/EBITDA 33.77
EV/Revenue 9.15
P/FCF 38.74
P/OCF 34.55
PEG 3.03
Earnings Yield 3.03%
FCF Yield 2.58%
OCF Yield 2.89%
Median P/E -7.37
Profitability & Returns (9)
MetricValue
Gross Margin 86.14%
Operating Margin -0.52%
Net Margin -1.33%
FCF Margin 0.06%
ROE -0.83%
ROA -0.51%
ROIC 2.13%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.37
Debt/Assets 0.23
Net Debt/EBITDA -1.19
Interest Coverage -0.23
Current Ratio 3.19
Quick Ratio 2.94
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 42.35%
Net Income Growth -10.70%
EPS Growth 4.95%
FCF Growth -2.22%
EBITDA Growth -7.77%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 43.00%
Revenue CAGR 5Y 34.78%
Revenue CAGR 10Y —
EPS CAGR 3Y 10.89%
EPS CAGR 5Y 16.40%
EPS CAGR 10Y —
FCF CAGR 3Y 12.10%
FCF CAGR 5Y 82.08%
FCF CAGR 10Y —
EBITDA CAGR 3Y 4.52%
EBITDA CAGR 5Y 4.93%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 9.76%
Net Income CAGR 5Y 17.17%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 40.5
IS Profitability 33.0
IS Balance Sheet 55.4
IS Earnings Quality 51.5
IS Growth 53.4
IS Value 34.6
IS Momentum 55.4
IS Safety 75.3
IS Quality 45.7
Altman Z-Score 18.99
Piotroski F-Score 3.39
Beneish M-Score -1.00
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.04%
Payout Ratio 4.27%
Buyback Yield 0.17%
Total Shareholder Return -10.03%
Growth Stability (4)
MetricValue
Revenue Stability 0.673
Earnings Stability 0.557
Earnings Persistence 0.728
Margin Stability 0.530
Medians (3)
MetricValue
Median P/E -7.37
Median P/B 4.08
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 83.55%
Holdings Matched 77
Total Holdings 82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms